Related Experiment Videos
Functioning human insulinomas. An immunohistochemical analysis of intracellular insulin processing
C Azzoni1, T D'Adda, G Tamburrano
1Department of Anatomic Pathology, University of Parma, Italy.
Virchows Archiv : an International Journal of Pathology
|December 31, 1998
Summary
This study investigated insulinoma tumors, finding that while insulin and proinsulin are abundant, the enzymes that process proinsulin are generally expressed normally. This suggests processing defects are unlikely to be the cause of most insulinomas.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Insulinomas are rare pancreatic neuroendocrine tumors.
- Proinsulin processing is crucial for insulin production.
- Defects in proinsulin processing enzymes have been hypothesized in insulinoma pathogenesis.
Purpose of the Study:
- To investigate the expression and localization of insulin, proinsulin, and key proinsulin processing enzymes in human insulinomas.
- To determine if altered expression or localization of these proteins contributes to insulinoma development.
Main Methods:
- Immunohistochemistry was performed on 67 insulinoma samples.
- Antibodies were used against insulin, proinsulin, chromogranin A, HISL-19, PC2, PC3, carboxypeptidase H (CPH), and 7B2.
- Results were scored based on the frequency of immunoreactive tumor cells.
Main Results:
- All tumors expressed insulin and proinsulin, with proinsulin localized to the Golgi apparatus.
- Proinsulin processing enzymes (PC2, PC3, CPH, 7B2) were expressed in virtually all insulinomas, often co-localized with insulin.
- High levels of cytoplasmic proinsulin were associated with normal enzyme expression, suggesting saturated processing capacity rather than enzyme defects.
Conclusions:
- The expression and localization of proinsulin-processing enzymes appear largely normal in most insulinomas.
- Altered expression or localization of these enzymes is unlikely to be the primary cause of insulinoma development.
- Further research may explore other mechanisms contributing to insulinoma pathogenesis.